TY  - JOUR
AU  - Sciascia, Savino
AU  - Lopez-Pedrera, Chary
AU  - Cecchi, Irene
AU  - Pecoraro, Clara
AU  - Roccatello, Dario
AU  - Cuadrado, Maria Jose
PY  - 2015
DO  - 10.1093/rheumatology/kev445
UR  - http://hdl.handle.net/10668/9808
T2  - Rheumatology (Oxford, England)
AB  - The current treatment of thrombotic APS patients includes long-term anticoagulation with oral vitamin K antagonists (VKAs), with warfarin being the one most commonly used. However, the use of VKAs can be challenging, especially in patients with APS....
LA  - en
PB  - Oxford University Press
KW  - Anti-phospholipid antibodies
KW  - Anti-phospholipid syndrome
KW  - Apixaban
KW  - Dabigatran
KW  - Rivaroxaban
KW  - Thrombosis
KW  - Administration, Oral
KW  - Anticoagulants
KW  - Antiphospholipid Syndrome
KW  - Antithrombins
KW  - Breast Feeding
KW  - Factor Xa Inhibitors
KW  - Female
KW  - Food-Drug Interactions
KW  - Hemorrhage
KW  - Humans
KW  - Kidney Diseases
KW  - Liver Diseases
KW  - Lupus Coagulation Inhibitor
KW  - Pregnancy
KW  - Pregnancy Complications
KW  - Thrombosis
KW  - Vitamin K
TI  - Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome.
TY  - research article
VL  - 55
ER  -